C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary

Juan Cosín-Sales1, Carmine Pizzi, Sue Brown

  • 1Coronary Artery Disease Research Unit, Department of Cardiological Sciences, St. George's Hospital Medical School, London, United Kingdom.

Insights

High-sensitivity C-reactive protein (hs-CRP) levels correlate with chest pain symptoms and ECG markers of myocardial ischemia in patients with chest pain and normal coronary angiograms. This suggests hs-CRP may indicate disease activity in these patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Ischemic Heart Disease

Background:

  • Patients with chest pain and normal coronary angiograms (CPNCA) often exhibit coronary microvascular endothelial dysfunction and myocardial ischemia.
  • Elevated high-sensitivity C-reactive protein (hs-CRP) is linked to atherogenesis and endothelial dysfunction.
  • The association between hs-CRP and disease activity in CPNCA patients remains underexplored.

Purpose of the Study:

  • To investigate the relationship between hs-CRP levels, clinical characteristics, exercise stress test responses, and ST-segment changes in CPNCA patients.
  • To determine if hs-CRP can serve as a marker for disease activity in CPNCA.

Main Methods:

  • A study involving 137 consecutive CPNCA patients.
  • Data collection included standardized angina questionnaires, exercise stress testing, 24-h ambulatory ECG monitoring (Holter), and hs-CRP measurements.
  • Statistical analysis utilized multivariate logistic regression.

Main Results:

  • Higher hs-CRP levels were observed in patients with more frequent and prolonged chest pain episodes.
  • Elevated hs-CRP correlated with ST-segment depression during exercise testing and Holter monitoring.
  • hs-CRP was the sole independent predictor of positive findings on both Holter monitoring and exercise testing.

Conclusions:

  • hs-CRP levels correlate significantly with symptoms and electrocardiogram (ECG) markers of myocardial ischemia in CPNCA patients.
  • Further research is warranted to elucidate the role of hs-CRP in the pathogenesis of angina within this patient group.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...